PL2869720T3 - Zastosowanie hydrolizatów białkowych bogatych w tryptofan - Google Patents
Zastosowanie hydrolizatów białkowych bogatych w tryptofanInfo
- Publication number
- PL2869720T3 PL2869720T3 PL13792757T PL13792757T PL2869720T3 PL 2869720 T3 PL2869720 T3 PL 2869720T3 PL 13792757 T PL13792757 T PL 13792757T PL 13792757 T PL13792757 T PL 13792757T PL 2869720 T3 PL2869720 T3 PL 2869720T3
- Authority
- PL
- Poland
- Prior art keywords
- protein hydrolysates
- rich protein
- tryptophan rich
- tryptophan
- hydrolysates
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title 1
- 108010009736 Protein Hydrolysates Proteins 0.000 title 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 title 1
- 239000003531 protein hydrolysate Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/227—Tryptophan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Husbandry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261721525P | 2012-11-02 | 2012-11-02 | |
| US201261721526P | 2012-11-02 | 2012-11-02 | |
| US201261721581P | 2012-11-02 | 2012-11-02 | |
| US201261721524P | 2012-11-02 | 2012-11-02 | |
| US201261721543P | 2012-11-02 | 2012-11-02 | |
| US201261721529P | 2012-11-02 | 2012-11-02 | |
| PCT/IB2013/059789 WO2014068499A1 (en) | 2012-11-02 | 2013-10-30 | Use of tryptophan rich protein hydrolysates |
| EP13792757.0A EP2869720B1 (en) | 2012-11-02 | 2013-10-30 | Use of tryptophan rich protein hydrolysates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2869720T3 true PL2869720T3 (pl) | 2018-08-31 |
Family
ID=49620251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13792757T PL2869720T3 (pl) | 2012-11-02 | 2013-10-30 | Zastosowanie hydrolizatów białkowych bogatych w tryptofan |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9516893B2 (pl) |
| EP (1) | EP2869720B1 (pl) |
| JP (2) | JP6436312B2 (pl) |
| KR (2) | KR20150082111A (pl) |
| CN (1) | CN104334037B (pl) |
| AU (1) | AU2013340318B2 (pl) |
| BR (1) | BR112014029991A2 (pl) |
| CA (1) | CA2875385C (pl) |
| EA (1) | EA030683B1 (pl) |
| ES (1) | ES2670942T3 (pl) |
| MX (1) | MX355027B (pl) |
| NZ (1) | NZ702486A (pl) |
| PL (1) | PL2869720T3 (pl) |
| TR (1) | TR201809789T4 (pl) |
| WO (1) | WO2014068499A1 (pl) |
| ZA (1) | ZA201408813B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012146651A1 (en) * | 2011-04-28 | 2012-11-01 | Dsm Ip Assets B.V. | Protein hydrolysates as agents for overcoming addiction |
| EP3082837B1 (en) * | 2013-12-18 | 2020-09-09 | DSM IP Assets B.V. | Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue |
| US20180070614A1 (en) * | 2016-09-15 | 2018-03-15 | Givaudan, S.A. | Flavored beverages |
| ES2668082B1 (es) * | 2016-10-13 | 2019-03-13 | Ingenius Biotech S L | Composicion de complemento dietetico |
| US11191289B2 (en) | 2018-04-30 | 2021-12-07 | Kraft Foods Group Brands Llc | Spoonable smoothie and methods of production thereof |
| DE102020102738A1 (de) * | 2020-02-04 | 2021-08-05 | Albert Wionzek | Eiszusammensetzung mit proteinogenen Aminosäuren |
| EP4312586A1 (en) * | 2021-03-25 | 2024-02-07 | Brain Luxury Inc. | A stable, emulsion-forming liquid composition comprising amino acids |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6579899B1 (en) * | 1998-07-16 | 2003-06-17 | Massachusetts Institute Of Technology | Composition for treatment of stress |
| EP1339735B1 (en) * | 2000-12-06 | 2007-03-21 | Campina Nederland Holding B.V. | Method for preparing tryptophan rich peptides |
| DE102005006241A1 (de) * | 2005-02-10 | 2006-08-17 | Patrick Faber | Verwendung von Tryptophan, Nahrungsmittel und Getränk |
| ATE548462T1 (de) | 2006-11-02 | 2012-03-15 | Dsm Ip Assets Bv | Verwendung von lysozymhydrolysaten enthaltend tryptophan |
| CN101535494B (zh) * | 2006-11-02 | 2014-04-09 | 帝斯曼知识产权资产管理有限公司 | 含有色氨酸的肽 |
| EP2271222B1 (en) * | 2008-04-29 | 2015-02-25 | DSM IP Assets B.V. | Process for the preparation of packaged heat-preserved aqueous drink comprising casein micelles and tryptophan-rich peptides, and product so obtained |
| US10172375B2 (en) * | 2008-04-29 | 2019-01-08 | Dsm Ip Assets B.V. | Compositions comprising carbohydrates and peptides which comprise tryptophan |
| CN102076228B (zh) * | 2008-04-29 | 2016-08-03 | 帝斯曼知识产权资产管理有限公司 | 与肽结合的色氨酸和与多肽结合的色氨酸的混合物 |
| AT505671B1 (de) | 2008-05-13 | 2009-03-15 | Evk Di Kerschhaggl Gmbh | Verfahren zum optischen detektieren von bewegten objekten |
| ES2545187T3 (es) * | 2010-10-05 | 2015-09-09 | Dsm Ip Assets B.V. | Empleo del hidrolizado de lisozima conteniendo triptófano para disminuir el apetito durante o después de situaciones de estrés |
-
2013
- 2013-10-30 CA CA2875385A patent/CA2875385C/en active Active
- 2013-10-30 KR KR1020147033680A patent/KR20150082111A/ko not_active IP Right Cessation
- 2013-10-30 BR BR112014029991A patent/BR112014029991A2/pt not_active Application Discontinuation
- 2013-10-30 AU AU2013340318A patent/AU2013340318B2/en active Active
- 2013-10-30 TR TR2018/09789T patent/TR201809789T4/tr unknown
- 2013-10-30 JP JP2015522248A patent/JP6436312B2/ja active Active
- 2013-10-30 ES ES13792757.0T patent/ES2670942T3/es active Active
- 2013-10-30 WO PCT/IB2013/059789 patent/WO2014068499A1/en active Application Filing
- 2013-10-30 EA EA201401197A patent/EA030683B1/ru not_active IP Right Cessation
- 2013-10-30 US US14/404,878 patent/US9516893B2/en active Active
- 2013-10-30 EP EP13792757.0A patent/EP2869720B1/en active Active
- 2013-10-30 CN CN201380029001.2A patent/CN104334037B/zh active Active
- 2013-10-30 PL PL13792757T patent/PL2869720T3/pl unknown
- 2013-10-30 NZ NZ702486A patent/NZ702486A/en unknown
- 2013-10-30 KR KR1020207033608A patent/KR102292817B1/ko active IP Right Grant
- 2013-10-30 MX MX2014014567A patent/MX355027B/es active IP Right Grant
-
2014
- 2014-12-01 ZA ZA2014/08813A patent/ZA201408813B/en unknown
-
2016
- 2016-11-18 JP JP2016225274A patent/JP6519882B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013340318A1 (en) | 2015-01-15 |
| WO2014068499A1 (en) | 2014-05-08 |
| CN104334037B (zh) | 2019-02-22 |
| AU2013340318B2 (en) | 2017-03-02 |
| TR201809789T4 (tr) | 2018-07-23 |
| EP2869720B1 (en) | 2018-04-25 |
| KR20200134342A (ko) | 2020-12-01 |
| JP2015524265A (ja) | 2015-08-24 |
| EA030683B1 (ru) | 2018-09-28 |
| KR20150082111A (ko) | 2015-07-15 |
| BR112014029991A2 (pt) | 2017-06-27 |
| CA2875385A1 (en) | 2014-05-08 |
| ZA201408813B (en) | 2017-08-30 |
| JP6436312B2 (ja) | 2018-12-12 |
| US9516893B2 (en) | 2016-12-13 |
| ES2670942T3 (es) | 2018-06-04 |
| MX355027B (es) | 2018-03-28 |
| CA2875385C (en) | 2020-11-24 |
| NZ702486A (en) | 2019-06-28 |
| KR102292817B1 (ko) | 2021-08-25 |
| JP2017079744A (ja) | 2017-05-18 |
| US20150296853A1 (en) | 2015-10-22 |
| CN104334037A (zh) | 2015-02-04 |
| JP6519882B2 (ja) | 2019-05-29 |
| EP2869720A1 (en) | 2015-05-13 |
| MX2014014567A (es) | 2015-03-05 |
| EA201401197A1 (ru) | 2015-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219964A1 (zh) | 治療性蛋白藥物物質的整合連續製造 | |
| EP2929045A4 (en) | PROTEIN EXPRESSION REINFORCING POLYPEPTIDES | |
| HK1213521A1 (zh) | 多肽的應用 | |
| SG11201603028SA (en) | Purification of proteins | |
| ZA201408813B (en) | Use of tryptophan rich protein hydrolysates | |
| HUE051648T2 (hu) | CCR3-gátlók használata | |
| HK1203161A1 (en) | Peptides and methods of using same | |
| EP2914293A4 (en) | METHOD OF USE OF FVIII POLYPEPTIDE | |
| DK2928505T3 (da) | Positron-emitterende radionuklidmærkede peptider til human upar-pet-billeddannelse | |
| HK1193532A2 (en) | Head massager | |
| PL2785420T3 (pl) | Kosmetyczne zastosowanie hydrolizatu kolagenu | |
| HK1249859A1 (zh) | Pcsk9肽疫苗 | |
| GB201208293D0 (en) | Hydrochlorice salt of peptide | |
| HK1204948A1 (en) | Radiation-sterilization-resistant protein composition | |
| GB201501101D0 (en) | Isotopic labelling of proteins | |
| SG10201507721SA (en) | CHO-GMT Recombinant Protein Expression | |
| EP3560952C0 (en) | VARIANT OF BPIFB4 PROTEIN | |
| EP2918600A4 (en) | NEW PEPTIDE AND ITS USE | |
| GB201223114D0 (en) | Novel peptide | |
| GB201213672D0 (en) | Protein | |
| HK1211952A1 (en) | Recombinant protein | |
| GB201113089D0 (en) | Protein hydrolysates | |
| GB201215901D0 (en) | Protein modification | |
| GB201200743D0 (en) | Protein bridges | |
| GB201103169D0 (en) | Protein expression |